Clinical outcomes in t(11;14) multiple myeloma.

被引：0
|
作者：
Moustafa, Muhamad Alhaj
Rajkumar, S. Vincent
Dispenzieri, Angela
Lacy, Martha
Gertz, Morie A.
Buadi, Francis
Dingli, David
Hayman, Suzanne R.
Kapoor, Prashant
Hwa, Yi Lisa
Lust, John Anthony
Go, Ronald S.
Kyle, Robert A.
Kumar, Shaji
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8592
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Molecular analysis of 11q13 breakpoints in multiple myeloma.
    Neri, A
    Ronchetti, D
    Finelli, P
    Richelda, R
    Fracchiolla, NS
    Luminari, S
    Lombardi, L
    Baldini, L
    Rocchi, M
    Maiolo, AT
    BLOOD, 1997, 90 (10) : 3578 - 3578
  • [42] Monoclonal immunoglobulin suppresses T cell function in multiple myeloma.
    Markovic, SN
    Lacy, MQ
    Crader, SC
    Greipp, PR
    BLOOD, 1999, 94 (10) : 117A - 117A
  • [43] Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)
    Suzuki, Kenshi
    Kasuga, Miho
    Miyazaki, Kanji
    Meshitsuka, Sohsuke
    Abe, Yu
    Yoshiki, Yumiko
    Tsukada, Nobuhiro
    BLOOD, 2015, 126 (23)
  • [44] Interphase FISH in multiple myeloma.
    Haaber, Jacob
    Sorensen, Anne G.
    Nibe, Anne
    Nielsen, Ole
    Abildgaard, Niels
    Plesner, Torben
    Kerndrup, Gitte B.
    BLOOD, 2006, 108 (11) : 344B - 344B
  • [45] Longitudinal Analysis of t(11;14) and t(4;14) Genomes Reveals Distinct Evolutionary Trajectories in Multiple Myeloma
    Hudson-Lund, Bethan
    Hughes, Daniel
    Sodi, Isabella
    Foster, Kane
    Lyon, Emma
    Laidler, Annabel
    Rees, Elise
    Galas-Filipowicz, Daria
    Fitzsimons, Evie
    Chavda, Selina
    Rashid, Ambreen
    Lecat, Catherine
    Mehta, Dipal
    Rahman, Jasmin
    Yoon, Jong Won
    Lee, Lydia
    Quezada, Sergio
    Srinivasan, Anandagopal
    Kazeroun, Mohammad
    Ansari-Pour, Naser
    Thakurta, Anjan
    Yong, Kwee
    Cribbs, Adam
    Gooding, Sarah
    Boyle, Eileen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S163 - S164
  • [46] Clinical synergism of Bortezomib and chemotherapy in relapsed and refractory multiple myeloma.
    Mazumder, A
    Chauvin, E
    Curran, K
    Disperati, P
    Jagannath, S
    BLOOD, 2003, 102 (11) : 390B - 390B
  • [47] Molecular analysis in the clinical follow up of patients with multiple myeloma.
    Marinelli, G
    Terragna, C
    Cavo, K
    Lemoli, RM
    Bandini, G
    Zamagni, E
    Ronconi, S
    Tosi, P
    Mangianti, S
    Motta, MR
    Zagarella, MS
    Testoni, N
    Amabile, M
    Ottaviani, E
    Tura, S
    BLOOD, 1999, 94 (10) : 384B - 384B
  • [48] Clinical grade SNaPshot genetic mutation profiling in multiple myeloma.
    O'Donnell, Elizabeth
    Mahindra, Anuj Kumar
    Yee, Andrew Jenho
    Birrer, Nicole
    Horick, Nora
    Finkelstein, Dianne M.
    Borger, Darrell R.
    Iafrato, A. John
    Raje, Noopur S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Clinical characteristics of young (age ≤50) patients with multiple myeloma.
    Niesvizky, R
    Lyons, L
    Michaeli, J
    BLOOD, 2000, 96 (11) : 279B - 279B
  • [50] T(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma
    Garand, R
    Avet-Loiseau, H
    Accard, F
    Moreau, P
    Harousseau, JL
    Bataille, R
    LEUKEMIA, 2003, 17 (10) : 2032 - 2035
12345